Chemotherapy, Mayo Clinic and Patient Care

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Chemotherapy

Mayo Clinic

Patient Care

TRE-5151 Receives FDA Fast Track Designation in Combination With Radiation Therapy for Prostate Cancer

Pharmacy Times

JULY 14, 2025

TRE-515 aims to extend patient lives and elevate current standards of care by combining radioligand therapy with novel drug approaches. SHOW MORE FDA fast-tracks TRE-515 for advanced prostate cancer, combining it with radiation therapy to enhance treatment outcomes and patient care. Mayo Clinic.

FDA

FDA Compounding Pharmacies Compounding Immunization

Navigating EGFR Mutations and ALK Fusions in Early-Stage Non-Small Cell Lung Cancer

Pharmacy Times

JUNE 19, 2025

1 Biomarker testing is relatively new in the treatment landscape for NSCLC but has proven incredibly important for personalizing patient care, transforming from a generic chemotherapy approach to a highly personalized, genomically driven treatment strategy. For advanced disease, chemotherapy was the standard.

Chemotherapy

Chemotherapy Compounding Pharmacies Hospitals Immunization

Pharmacy Technician Pulse

TRE-5151 Receives FDA Fast Track Designation in Combination With Radiation Therapy for Prostate Cancer

Navigating EGFR Mutations and ALK Fusions in Early-Stage Non-Small Cell Lung Cancer

Stay Connected